Darzi, Andrea J.
Busse, Jason W.
Phillips, Mark R. http://orcid.org/0000-0003-0923-261X
Singh, Rishi P.
Holz, Frank G.
Thabane, Lehana http://orcid.org/0000-0003-0355-9734
Bhandari, Mohit http://orcid.org/0000-0001-9608-4808
Chaudhary, Varun http://orcid.org/0000-0002-9988-4146
Wykoff, Charles C.
Sivaprasad, Sobha
Kaiser, Peter
Sarraf, David
Bakri, Sophie J.
Garg, Sunir J.
Singh, Rishi P.
Wong, Tien Y.
Guymer, Robyn H.
,
Article History
Received: 1 December 2021
Revised: 2 December 2021
Accepted: 6 December 2021
First Online: 24 January 2022
Competing interests
: AJD: Nothing to disclose. JWB: Nothing to disclose. MRP: Nothing to disclose. RPS: Consultant: Novartis, Genentech/Roche, Alcon, Regeneron, Bayer, Optos, Genentech, Apellis – unrelated to this study. FGH: Research funds: Acucela, Allergan, Apellis, Bayer, Bioeq/Formycon, Roche/Genentech, Geuder, Heidelberg Engineering, IvericBio, Kanghong, Novartis, NightStarX, Zeiss; Personal fees: Boehringer-Ingelheim, Grayburg Vision, LinBioscience, Pixium Vision, Stealth BioTherapeutics, Aerie, Oxurion – unrelated to this study. LT: Nothing to disclose. MB: Research funds: Pendopharm, Bioventus, Acumed – unrelated to this study. VC: Advisory Board Member: Alcon, Roche, Bayer, Novartis; Grants: Bayer, Novartis – unrelated to this study.
Free to read: This content has been made available to all.